STAA - Eye On Growth: BROADWOOD PARTNERS LP Adds $13.70M Of Staar Surgical Stock To Portfolio | Benzinga
A notable insider purchase on December 1, was reported by BROADWOOD PARTNERS LP, 10% Owner at Staar Surgical (NASDAQ:STAA), based on the most recent SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that LP purchased 434,991 shares of Staar Surgical. The total transaction amounted to $13,703,830.
In the Friday's morning session, Staar Surgical's shares are currently trading at $31.35, experiencing a down of 0.03%.
About Staar Surgical
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.
Financial Insights: Staar Surgical
Positive Revenue Trend: Examining Staar Surgical's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.6% as of 30 September, 2023, showcasing a substantial increase in top-line earnings. When compared to others in the ...